Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Displaying results 1 - 10 of 85
Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder
Published: May 2023
This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Published: December 2021
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Advisory: Prescription Stimulant Misuse Among Youth and Young Adults
Published: November 2021
This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
Treating Concurrent Substance Use Among Adults
Published: September 2021
This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).
TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
TIP 63: Medications for Opioid Use Disorder - Full Document
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Talk. They Hear You. Talking with Your Teen About Opioids: Keeping Your Kids Safe – Parent Brochure
Published: February 2021
A brochure for parents and caregivers about the risks associated with misusing prescription pain medications for teens and the importance of having conversations with their children to help them avoid taking medication that is not theirs.
Use of Medication-Assisted Treatment in Emergency Departments
Published: January 2021
This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.
Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets
Published: January 2021
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue (Spanish version) - La crisis de los opioides en la población Hispana/Latina: un asunto urgente
Published: October 2020
Issue brief presents recent data on prevalence of opioid misuse & death rates in the Hispanic/Latino population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; & the importance of community voice.